Atria Investments LLC Astrazeneca PLC Transaction History

Atria Investments LLC

  • $7.49 Billion
  • Q4 2024

A detailed history of Atria Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Atria Investments LLC holds 103,688 shares of AZN stock, worth $7.21 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
103,688
Previous 106,868 2.98%
Holding current value
$7.21 Million
Previous $8.33 Million 18.42%
% of portfolio
0.09%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$63.2 - $79.58 $200,976 - $253,064
-3,180 Reduced 2.98%
103,688 $6.79 Million
Q3 2024

Nov 01, 2024
BUY
$76.67 - $87.62 $723,074 - $826,344
9,431 Added 9.68%
106,868 $8.33 Million
Q2 2024

Aug 13, 2024
BUY
$66.81 - $80.83 $813,879 - $984,671
12,182 Added 14.29%
97,437 $7.6 Million
Q1 2024

May 21, 2024
BUY
$61.03 - $69.57 $38,387 - $43,759
629 Added 0.74%
85,255 $5.78 Million
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $314,277 - $351,803
5,078 Added 6.38%
84,626 $5.7 Million
Q3 2023

Nov 07, 2023
BUY
$64.85 - $71.7 $521,653 - $576,754
8,044 Added 11.25%
79,548 $5.39 Million
Q2 2023

Aug 04, 2023
SELL
$69.91 - $75.81 $557,392 - $604,433
-7,973 Reduced 10.03%
71,504 $5.12 Million
Q1 2023

May 10, 2023
BUY
$63.15 - $71.6 $286,195 - $324,491
4,532 Added 6.05%
79,477 $5.52 Million
Q4 2022

Jan 31, 2023
SELL
$54.21 - $70.44 $101,806 - $132,286
-1,878 Reduced 2.44%
74,945 $5.08 Million
Q3 2022

Nov 01, 2022
BUY
$53.02 - $135.75 $790,263 - $2.02 Million
14,905 Added 24.07%
76,823 $4.21 Million
Q2 2022

Aug 11, 2022
SELL
$59.26 - $71.14 $952,900 - $1.14 Million
-16,080 Reduced 20.62%
61,918 $4.09 Million
Q1 2022

May 02, 2022
SELL
$55.72 - $67.12 $67,421 - $81,215
-1,210 Reduced 1.53%
77,998 $5.17 Million
Q4 2021

Feb 04, 2022
BUY
$54.02 - $63.83 $179,832 - $212,490
3,329 Added 4.39%
79,208 $4.61 Million
Q3 2021

Nov 16, 2021
BUY
$55.56 - $60.79 $1.18 Million - $1.29 Million
21,206 Added 38.79%
75,879 $4.56 Million
Q2 2021

Aug 10, 2021
BUY
$48.42 - $60.18 $509,668 - $633,454
10,526 Added 23.84%
54,673 $3.28 Million
Q1 2021

May 11, 2021
SELL
$47.16 - $54.44 $131,765 - $152,105
-2,794 Reduced 5.95%
44,147 $2.2 Million
Q4 2020

Feb 12, 2021
BUY
$48.52 - $58.02 $258,563 - $309,188
5,329 Added 12.81%
46,941 $2.35 Million
Q3 2020

Nov 05, 2020
SELL
$53.07 - $61.1 $70,742 - $81,446
-1,333 Reduced 3.1%
41,612 $2.28 Million
Q2 2020

Sep 22, 2020
BUY
$43.1 - $55.31 $242,566 - $311,284
5,628 Added 15.08%
42,945 $2.27 Million
Q1 2020

May 15, 2020
BUY
$37.79 - $51.33 $335,083 - $455,143
8,867 Added 31.17%
37,317 $1.67 Million
Q4 2019

Feb 11, 2020
BUY
$42.46 - $50.46 $1.21 Million - $1.44 Million
28,450 New
28,450 $1.42 Million
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $555,942 - $630,077
-13,857 Closed
0 $0
Q2 2019

Aug 26, 2019
BUY
$37.28 - $41.68 $516,588 - $577,559
13,857 New
13,857 $616,000
Q2 2019

Aug 09, 2019
SELL
$37.28 - $41.68 $557,261 - $623,032
-14,948 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$35.49 - $43.02 $45,817 - $55,538
-1,291 Reduced 7.95%
14,948 $595,000
Q4 2018

Feb 12, 2019
SELL
$36.86 - $41.49 $278,919 - $313,954
-7,567 Reduced 31.79%
16,239 $617,000
Q3 2018

Oct 09, 2018
SELL
$34.76 - $39.72 $287,743 - $328,802
-8,278 Reduced 25.8%
23,806 $942,000
Q2 2018

Jul 13, 2018
SELL
$34.55 - $37.05 $155,267 - $166,502
-4,494 Reduced 12.29%
32,084 $1.13 Million
Q1 2018

Apr 30, 2018
BUY
$32.97 - $36.63 $101,646 - $112,930
3,083 Added 9.2%
36,578 $1.28 Million
Q4 2017

Jan 16, 2018
BUY
$32.09 - $34.78 $223,956 - $242,729
6,979 Added 26.32%
33,495 $1.16 Million
Q3 2017

Oct 12, 2017
BUY
$28.96 - $34.0 $767,903 - $901,544
26,516
26,516 $898,000

Others Institutions Holding AZN

# of Institutions
1,381
Shares Held
475M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $216B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email